Intuitive Surgical, Inc. $ISRG Shares Sold by Legacy Financial Advisors Inc.

Legacy Financial Advisors Inc. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% in the first quarter, HoldingsChannel.com reports. The fund owned 2,264 shares of the medical equipment provider’s stock after selling 61 shares during the quarter. Legacy Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $1,121,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in ISRG. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. grew its position in shares of Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp grew its position in shares of Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP grew its position in shares of Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at $1,715,899,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 7,893 shares of the business’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the transaction, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,839 shares of company stock worth $7,896,972. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Citigroup reaffirmed a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. Finally, Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $595.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $481.28 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a 50-day moving average of $507.85 and a 200-day moving average of $524.14. The company has a market capitalization of $172.53 billion, a price-to-earnings ratio of 67.12, a PEG ratio of 5.03 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the previous year, the firm posted $1.78 earnings per share. The company’s revenue was up 21.4% compared to the same quarter last year. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.